These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Development of a genetically engineered vaccine against feline leukemia virus infection.
    Author: Kensil CR, Barrett C, Kushner N, Beltz G, Storey J, Patel U, Recchia J, Aubert A, Marciani D.
    Journal: J Am Vet Med Assoc; 1991 Nov 15; 199(10):1423-7. PubMed ID: 1666096.
    Abstract:
    A genetically engineered subunit vaccine against FeLV infection was developed. The protective immunogen in the vaccine was a purified recombinant protein containing the entire amino acid sequence of FeLV subgroup A gp70 envelope protein. The optimal adjuvant was determined to be a highly purified saponin, QS-21, derived from Quillaja saponaria Molina. A vaccine formulation containing the recombinant protein, QS-21, and aluminum hydroxide was tested in specific-pathogen-free kittens and was shown to induce neutralizing antibodies as well as appreciable antibody responses to native gp70 by enzyme immunoassay and protein (western) immunoblot analysis and of whole virus preparations.
    [Abstract] [Full Text] [Related] [New Search]